标题
Survivin: a unique target for tumor therapy
作者
关键词
Survivin, Immunotherapy, Apoptosis, IAPs
出版物
Cancer Cell International
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-06-24
DOI
10.1186/s12935-016-0326-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Essential Role for Survivin in the Proliferative Expansion of Progenitor and Mature B Cells
- (2016) Ana V. Miletic et al. JOURNAL OF IMMUNOLOGY
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- The Functional Repertoire of Survivin's Tails
- (2015) Sally P Wheatley CELL CYCLE
- Recent Advances on Small-Molecule Survivin Inhibitors
- (2015) Min Xiao et al. CURRENT MEDICINAL CHEMISTRY
- Mycobacterium indicus pranii induces dendritic cell activation, survival, and Th1/Th17 polarization potential in a TLR-dependent manner
- (2015) Pawan Kumar et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Design, Synthesis and Structure-Activity Relationship Studies of Novel Survivin Inhibitors with Potent Anti-Proliferative Properties
- (2015) Min Xiao et al. PLoS One
- Cancer and the Immune System: Basic Concepts and Targets for Intervention
- (2015) Drew Pardoll SEMINARS IN ONCOLOGY
- Preclinical development of HIvax: Human survivin highly immunogenic vaccines
- (2015) Peter R Hoffmann et al. Human Vaccines & Immunotherapeutics
- Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients
- (2015) Neil L Berinstein et al. OncoImmunology
- The Survivin −31 Snp in Human Colorectal Cancer Correlates with Survivin Splice Variant Expression and Improved Overall Survival
- (2015) Anna G. Antonacopoulou et al. Analytical Cellular Pathology
- siRNA-mediated Silencing of Survivin Inhibits Proliferation and Enhances Etoposide Chemosensitivity in Acute Myeloid Leukemia Cells
- (2014) Hadi Karami et al. Asian Pacific Journal of Cancer Prevention
- Immunologic response to the survivin-derived multi-epitope vaccine EMD640744 in patients with advanced solid tumors
- (2014) Volker Lennerz et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- KLF5 Regulates the Integrity and Oncogenicity of Intestinal Stem Cells
- (2014) T. Nakaya et al. CANCER RESEARCH
- Identification of novel helper epitope peptides of Survivin cancer-associated antigen applicable to developing helper/killer-hybrid epitope long peptide cancer vaccine
- (2014) Junya Ohtake et al. IMMUNOLOGY LETTERS
- Comprehensive Analysis of HLA-DR- and HLA-DP4-Restricted CD4+ T Cell Response Specific for the Tumor-Shared Antigen Survivin in Healthy Donors and Cancer Patients
- (2014) X.-F. Wang et al. JOURNAL OF IMMUNOLOGY
- Survivin modulates genes with divergent molecular functions and regulates proliferation of hematopoietic stem cells through Evi-1
- (2014) S Fukuda et al. LEUKEMIA
- Survivin expression promotes VEGF-induced tumor angiogenesis via PI3K/Akt enhanced β-catenin/Tcf-Lef dependent transcription
- (2014) Jaime G Fernández et al. Molecular Cancer
- Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas
- (2014) T. Doucette et al. NEURO-ONCOLOGY
- Differential localization and high expression of SURVIVIN splice variants in human embryonic stem cells but not in differentiated cells implicate a role for SURVIVIN in pluripotency
- (2014) Amber N. Mull et al. Stem Cell Research
- Sox2 protects neural stem cells from apoptosis via up-regulating survivin expression
- (2013) Ruopeng Feng et al. BIOCHEMICAL JOURNAL
- Clinico-pathologic relevance of Survivin splice variant expression in cancer
- (2013) Rosalia de Necochea-Campion et al. CANCER LETTERS
- Survivin promotion of melanoma metastasis requires upregulation of α 5 integrin
- (2013) Jodi A. McKenzie et al. CARCINOGENESIS
- Tapping the treasure of intracellular oncotargets with immunotherapy
- (2013) Cheng William Hong et al. FEBS LETTERS
- Fowlpox-based survivin vaccination for malignant mesothelioma therapy
- (2013) Pietro Bertino et al. INTERNATIONAL JOURNAL OF CANCER
- CD4+ T Cells Play a Critical Role in the Generation of Primary and Memory Antitumor Immune Responses Elicited by SA-4-1BBL and TAA-Based Vaccines in Mouse Tumor Models
- (2013) Rajesh K. Sharma et al. PLoS One
- Survivin – biology and potential as a therapeutic target in oncology
- (2013) Jang-Yang Chang et al. OncoTargets and Therapy
- Human Vaccines & Immunotherapeutics
- (2013) Eva M. Riedmann Human Vaccines & Immunotherapeutics
- Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma
- (2012) Jürgen C. Becker et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination
- (2012) E. H. J. G. Aarntzen et al. CANCER RESEARCH
- Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer
- (2012) Xiaopeng Cai et al. Diagnostic Pathology
- YM155 Induces EGFR Suppression in Pancreatic Cancer Cells
- (2012) Young-Soon Na et al. PLoS One
- A Novel Small Molecule FL118 That Selectively Inhibits Survivin, Mcl-1, XIAP and cIAP2 in a p53-Independent Manner, Shows Superior Antitumor Activity
- (2012) Xiang Ling et al. PLoS One
- SA-4-1BBL Costimulation Inhibits Conversion of Conventional CD4+ T Cells into CD4+FoxP3+ T Regulatory Cells by Production of IFN-γ
- (2012) Shravan Madireddi et al. PLoS One
- Prime-Boost Vaccination with SA-4-1BBL Costimulatory Molecule and Survivin Eradicates Lung Carcinoma in CD8+ T and NK Cell Dependent Manner
- (2012) Abhishek K. Srivastava et al. PLoS One
- OCT4 Positively Regulates Survivin Expression to Promote Cancer Cell Proliferation and Leads to Poor Prognosis in Esophageal Squamous Cell Carcinoma
- (2012) Chunguang Li et al. PLoS One
- Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer
- (2012) Salma Khan et al. PLoS One
- Immunogenic enhancement and clinical effect by type-I interferon of anti-apoptotic protein, survivin-derived peptide vaccine, in advanced colorectal cancer patients
- (2011) Hidekazu Kameshima et al. CANCER SCIENCE
- Induction of HLA-DP4–Restricted Anti-Survivin Th1 and Th2 Responses Using an Artificial Antigen-Presenting Cell
- (2011) Makito Tanaka et al. CLINICAL CANCER RESEARCH
- Immunotherapeutic efficacy of Mycobacterium indicus pranii in eliciting anti-tumor T cell responses: Critical roles of IFNγ
- (2011) Srabanti Rakshit et al. INTERNATIONAL JOURNAL OF CANCER
- Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patients
- (2011) Melanie Widenmeyer et al. INTERNATIONAL JOURNAL OF CANCER
- Type I interferon is selectively required by dendritic cells for immune rejection of tumors
- (2011) Mark S. Diamond et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Overexpression of survivin is correlated with increased invasion and metastasis of colorectal cancer
- (2011) Xiao-Yuan Chu et al. JOURNAL OF SURGICAL ONCOLOGY
- Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
- (2011) Ronan J Kelly et al. Molecular Cancer
- Survivin promotes glioma angiogenesis through vascular endothelial growth factor and basic fibroblast growth factor in vitro and in vivo
- (2011) Peng Wang et al. MOLECULAR CARCINOGENESIS
- Survivin is released from cancer cells via exosomes
- (2010) Salma Khan et al. APOPTOSIS
- Monoclonal antibodies target intracellular PRL phosphatases to inhibit cancer metastases in mice
- (2010) Ke Guo et al. CANCER BIOLOGY & THERAPY
- A survivin double point mutant has potent inhibitory effect on the growth of hepatocellular cancer cells
- (2010) Rui Zhang et al. CANCER BIOLOGY & THERAPY
- GDP366, a novel small molecule dual inhibitor of survivin and Op18, induces cell growth inhibition, cellular senescence and mitotic catastrophe in human cancer cells
- (2010) Xianping Shi et al. CANCER BIOLOGY & THERAPY
- IAP Regulation of Metastasis
- (2010) Swarna Mehrotra et al. CANCER CELL
- A cell-permeable dominant-negative survivin protein induces apoptosis and sensitizes prostate cancer cells to TNF-α therapy
- (2010) Chun Hei Antonio Cheung et al. Cancer Cell International
- Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model
- (2010) Hidenobu Ishizaki et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phase I clinical trial of survivin-derived peptide vaccine therapy for patients with advanced or recurrent oral cancer
- (2010) Akihiro Miyazaki et al. CANCER SCIENCE
- Tumor Survivin Is Downregulated by the Antisense Oligonucleotide LY2181308: A Proof-of-Concept, First-in-Human Dose Study
- (2010) D. C. Talbot et al. CLINICAL CANCER RESEARCH
- Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
- (2010) Redas Trepiakas et al. CYTOTHERAPY
- Survivin Is a Potential Mediator of Prostate Cancer Metastasis
- (2010) Min Zhang et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Survivin Selectively Modulates Genes Deregulated in Human Leukemia Stem Cells
- (2010) Seiji Fukuda et al. Journal of Oncology
- Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential
- (2009) S Khan et al. BRITISH JOURNAL OF CANCER
- Phase I clinical study of anti-apoptosis protein survivin-derived peptide vaccination for patients with advanced or recurrent urothelial cancer
- (2009) Ichiya Honma et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Identification and characterization of survivin-derived H-2Kb-restricted CTL epitopes
- (2009) Uta B. Hofmann et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Multicenter Phase II Trial of YM155, a Small-Molecule Suppressor of Survivin, in Patients With Advanced, Refractory, Non–Small-Cell Lung Cancer
- (2009) Giuseppe Giaccone et al. JOURNAL OF CLINICAL ONCOLOGY
- Increased Survivin Expression Confers Chemoresistance to Tumor-Associated Endothelial Cells
- (2008) Jenilyn J. Virrey et al. AMERICAN JOURNAL OF PATHOLOGY
- Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP21
- (2008) John W. Blankenship et al. BIOCHEMICAL JOURNAL
- Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
- (2008) A. C. Mita et al. CLINICAL CANCER RESEARCH
- Clinical and immunological evaluation of anti-apoptosis protein, survivin-derived peptide vaccine in phase I clinical study for patients with advanced or recurrent breast cancer
- (2008) Tetsuhiro Tsuruma et al. Journal of Translational Medicine
- IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesis
- (2008) Mads Gyrd-Hansen et al. NATURE CELL BIOLOGY
- IAP-targeted therapies for cancer
- (2008) E C LaCasse et al. ONCOGENE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started